nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—ABCC2—epilepsy syndrome	0.127	0.444	CbGaD
Daunorubicin—ABCG2—epilepsy syndrome	0.112	0.393	CbGaD
Daunorubicin—ABCB1—epilepsy syndrome	0.0466	0.163	CbGaD
Daunorubicin—ABCC2—Levetiracetam—epilepsy syndrome	0.0327	0.0763	CbGbCtD
Daunorubicin—CYP1B1—Propofol—epilepsy syndrome	0.0299	0.0697	CbGbCtD
Daunorubicin—CYP1B1—Phenobarbital—epilepsy syndrome	0.0285	0.0666	CbGbCtD
Daunorubicin—ABCB11—Phenobarbital—epilepsy syndrome	0.0285	0.0666	CbGbCtD
Daunorubicin—ABCC1—Phenobarbital—epilepsy syndrome	0.0203	0.0473	CbGbCtD
Daunorubicin—ABCC2—Carbamazepine—epilepsy syndrome	0.0188	0.0438	CbGbCtD
Daunorubicin—ABCC2—Phenytoin—epilepsy syndrome	0.0168	0.0393	CbGbCtD
Daunorubicin—ABCC2—Phenobarbital—epilepsy syndrome	0.015	0.035	CbGbCtD
Daunorubicin—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.015	0.0349	CbGbCtD
Daunorubicin—CYP1A1—Propofol—epilepsy syndrome	0.0131	0.0306	CbGbCtD
Daunorubicin—CYP1A1—Phenobarbital—epilepsy syndrome	0.0125	0.0292	CbGbCtD
Daunorubicin—ABCB1—Levetiracetam—epilepsy syndrome	0.0107	0.0249	CbGbCtD
Daunorubicin—CYP3A5—Carbamazepine—epilepsy syndrome	0.0094	0.0219	CbGbCtD
Daunorubicin—CYP3A5—Phenytoin—epilepsy syndrome	0.00844	0.0197	CbGbCtD
Daunorubicin—CYP3A5—Phenobarbital—epilepsy syndrome	0.00752	0.0175	CbGbCtD
Daunorubicin—CYP3A5—Midazolam—epilepsy syndrome	0.00741	0.0173	CbGbCtD
Daunorubicin—ABCB1—Clobazam—epilepsy syndrome	0.00739	0.0172	CbGbCtD
Daunorubicin—CYP3A5—Diazepam—epilepsy syndrome	0.00713	0.0166	CbGbCtD
Daunorubicin—ABCB1—Lamotrigine—epilepsy syndrome	0.00711	0.0166	CbGbCtD
Daunorubicin—CYP1A2—Carbamazepine—epilepsy syndrome	0.007	0.0163	CbGbCtD
Daunorubicin—CYP1A2—Primidone—epilepsy syndrome	0.00653	0.0152	CbGbCtD
Daunorubicin—ABCB1—Carbamazepine—epilepsy syndrome	0.00612	0.0143	CbGbCtD
Daunorubicin—CYP1A2—Propofol—epilepsy syndrome	0.00586	0.0137	CbGbCtD
Daunorubicin—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00584	0.0136	CbGbCtD
Daunorubicin—CYP3A5—Valproic Acid—epilepsy syndrome	0.00562	0.0131	CbGbCtD
Daunorubicin—CYP1A2—Phenobarbital—epilepsy syndrome	0.0056	0.0131	CbGbCtD
Daunorubicin—ABCB1—Phenytoin—epilepsy syndrome	0.00549	0.0128	CbGbCtD
Daunorubicin—CYP3A4—Trimethadione—epilepsy syndrome	0.00543	0.0127	CbGbCtD
Daunorubicin—CYP3A4—Felbamate—epilepsy syndrome	0.00543	0.0127	CbGbCtD
Daunorubicin—CYP1A2—Diazepam—epilepsy syndrome	0.0053	0.0124	CbGbCtD
Daunorubicin—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0051	0.0119	CbGbCtD
Daunorubicin—ABCB1—Phenobarbital—epilepsy syndrome	0.00489	0.0114	CbGbCtD
Daunorubicin—ABCB1—Midazolam—epilepsy syndrome	0.00482	0.0113	CbGbCtD
Daunorubicin—ABCB1—Diazepam—epilepsy syndrome	0.00464	0.0108	CbGbCtD
Daunorubicin—CYP3A4—Clonazepam—epilepsy syndrome	0.00462	0.0108	CbGbCtD
Daunorubicin—CYP3A4—Clobazam—epilepsy syndrome	0.00443	0.0103	CbGbCtD
Daunorubicin—CYP1A2—Valproic Acid—epilepsy syndrome	0.00418	0.00975	CbGbCtD
Daunorubicin—CYP3A4—Rufinamide—epilepsy syndrome	0.00376	0.00878	CbGbCtD
Daunorubicin—CYP3A4—Carbamazepine—epilepsy syndrome	0.00367	0.00855	CbGbCtD
Daunorubicin—CYP3A4—Primidone—epilepsy syndrome	0.00342	0.00799	CbGbCtD
Daunorubicin—CYP3A4—Phenytoin—epilepsy syndrome	0.00329	0.00767	CbGbCtD
Daunorubicin—CYP3A4—Propofol—epilepsy syndrome	0.00307	0.00716	CbGbCtD
Daunorubicin—CYP3A4—Phenobarbital—epilepsy syndrome	0.00293	0.00684	CbGbCtD
Daunorubicin—CYP3A4—Acetazolamide—epilepsy syndrome	0.00293	0.00684	CbGbCtD
Daunorubicin—CYP3A4—Midazolam—epilepsy syndrome	0.00289	0.00674	CbGbCtD
Daunorubicin—CYP3A4—Diazepam—epilepsy syndrome	0.00278	0.00648	CbGbCtD
Daunorubicin—CYP3A4—Zonisamide—epilepsy syndrome	0.00271	0.00633	CbGbCtD
Daunorubicin—CYP3A4—Valproic Acid—epilepsy syndrome	0.00219	0.00511	CbGbCtD
Daunorubicin—NR5A1—hindbrain—epilepsy syndrome	0.00217	0.0786	CbGeAlD
Daunorubicin—CYP3A4—Topiramate—epilepsy syndrome	0.00198	0.00461	CbGbCtD
Daunorubicin—TOP2B—hindbrain—epilepsy syndrome	0.00138	0.0501	CbGeAlD
Daunorubicin—TOP2A—Pyrimethamine—Lamotrigine—epilepsy syndrome	0.00137	0.768	CbGdCrCtD
Daunorubicin—NR5A1—brainstem—epilepsy syndrome	0.00124	0.0451	CbGeAlD
Daunorubicin—Doxorubicin—NOS1—epilepsy syndrome	0.00084	0.345	CrCbGaD
Daunorubicin—YWHAG—forebrain—epilepsy syndrome	0.000792	0.0287	CbGeAlD
Daunorubicin—TOP2B—brainstem—epilepsy syndrome	0.00079	0.0287	CbGeAlD
Daunorubicin—TOP2B—forebrain—epilepsy syndrome	0.000763	0.0277	CbGeAlD
Daunorubicin—YWHAG—telencephalon—epilepsy syndrome	0.000728	0.0264	CbGeAlD
Daunorubicin—TOP2B—telencephalon—epilepsy syndrome	0.000701	0.0255	CbGeAlD
Daunorubicin—NR5A1—head—epilepsy syndrome	0.000686	0.0249	CbGeAlD
Daunorubicin—NR5A1—nervous system—epilepsy syndrome	0.00065	0.0236	CbGeAlD
Daunorubicin—NR5A1—central nervous system—epilepsy syndrome	0.000626	0.0227	CbGeAlD
Daunorubicin—NR5A1—cerebellum—epilepsy syndrome	0.000612	0.0222	CbGeAlD
Daunorubicin—YWHAG—medulla oblongata—epilepsy syndrome	0.000572	0.0208	CbGeAlD
Daunorubicin—TOP2B—medulla oblongata—epilepsy syndrome	0.000551	0.02	CbGeAlD
Daunorubicin—YWHAG—midbrain—epilepsy syndrome	0.000523	0.019	CbGeAlD
Daunorubicin—YWHAG—spinal cord—epilepsy syndrome	0.00051	0.0185	CbGeAlD
Daunorubicin—TOP2B—midbrain—epilepsy syndrome	0.000504	0.0183	CbGeAlD
Daunorubicin—NR5A1—brain—epilepsy syndrome	0.000497	0.0181	CbGeAlD
Daunorubicin—TOP2B—spinal cord—epilepsy syndrome	0.000491	0.0178	CbGeAlD
Daunorubicin—ABCC6—head—epilepsy syndrome	0.000481	0.0175	CbGeAlD
Daunorubicin—YWHAG—head—epilepsy syndrome	0.000453	0.0165	CbGeAlD
Daunorubicin—Doxorubicin—NOS2—epilepsy syndrome	0.000441	0.181	CrCbGaD
Daunorubicin—ABCC10—telencephalon—epilepsy syndrome	0.000439	0.0159	CbGeAlD
Daunorubicin—TOP2B—head—epilepsy syndrome	0.000437	0.0159	CbGeAlD
Daunorubicin—POR—medulla oblongata—epilepsy syndrome	0.000435	0.0158	CbGeAlD
Daunorubicin—YWHAG—nervous system—epilepsy syndrome	0.00043	0.0156	CbGeAlD
Daunorubicin—TOP2B—nervous system—epilepsy syndrome	0.000414	0.015	CbGeAlD
Daunorubicin—YWHAG—central nervous system—epilepsy syndrome	0.000414	0.015	CbGeAlD
Daunorubicin—YWHAG—cerebellum—epilepsy syndrome	0.000404	0.0147	CbGeAlD
Daunorubicin—TOP2B—central nervous system—epilepsy syndrome	0.000399	0.0145	CbGeAlD
Daunorubicin—POR—midbrain—epilepsy syndrome	0.000397	0.0144	CbGeAlD
Daunorubicin—TOP2B—cerebellum—epilepsy syndrome	0.00039	0.0141	CbGeAlD
Daunorubicin—POR—spinal cord—epilepsy syndrome	0.000388	0.0141	CbGeAlD
Daunorubicin—Idarubicin—CYP2D6—epilepsy syndrome	0.000346	0.142	CrCbGaD
Daunorubicin—CYP1B1—telencephalon—epilepsy syndrome	0.000345	0.0125	CbGeAlD
Daunorubicin—ABCC10—medulla oblongata—epilepsy syndrome	0.000345	0.0125	CbGeAlD
Daunorubicin—YWHAG—brain—epilepsy syndrome	0.000328	0.0119	CbGeAlD
Daunorubicin—TOP2B—brain—epilepsy syndrome	0.000317	0.0115	CbGeAlD
Daunorubicin—ABCC10—midbrain—epilepsy syndrome	0.000315	0.0114	CbGeAlD
Daunorubicin—ABCC1—telencephalon—epilepsy syndrome	0.000311	0.0113	CbGeAlD
Daunorubicin—ABCC10—spinal cord—epilepsy syndrome	0.000308	0.0112	CbGeAlD
Daunorubicin—POR—cerebellum—epilepsy syndrome	0.000307	0.0112	CbGeAlD
Daunorubicin—Doxorubicin—ABCC2—epilepsy syndrome	0.000293	0.12	CrCbGaD
Daunorubicin—Doxorubicin—ABCG2—epilepsy syndrome	0.000259	0.106	CrCbGaD
Daunorubicin—ABCG2—telencephalon—epilepsy syndrome	0.000257	0.00934	CbGeAlD
Daunorubicin—POR—brain—epilepsy syndrome	0.00025	0.00907	CbGeAlD
Daunorubicin—ABCC10—cerebellum—epilepsy syndrome	0.000244	0.00886	CbGeAlD
Daunorubicin—CYP1B1—head—epilepsy syndrome	0.000215	0.00781	CbGeAlD
Daunorubicin—CYP1B1—nervous system—epilepsy syndrome	0.000204	0.0074	CbGeAlD
Daunorubicin—ABCG2—medulla oblongata—epilepsy syndrome	0.000202	0.00734	CbGeAlD
Daunorubicin—ABCC10—brain—epilepsy syndrome	0.000198	0.00719	CbGeAlD
Daunorubicin—CYP1B1—central nervous system—epilepsy syndrome	0.000196	0.00713	CbGeAlD
Daunorubicin—CYP1B1—cerebellum—epilepsy syndrome	0.000192	0.00697	CbGeAlD
Daunorubicin—ABCG2—midbrain—epilepsy syndrome	0.000185	0.0067	CbGeAlD
Daunorubicin—TOP2A—Bortezomib—Lacosamide—epilepsy syndrome	0.000181	0.101	CbGdCrCtD
Daunorubicin—ABCG2—spinal cord—epilepsy syndrome	0.00018	0.00654	CbGeAlD
Daunorubicin—ABCC1—cerebellum—epilepsy syndrome	0.000173	0.00626	CbGeAlD
Daunorubicin—CYP1B1—brain—epilepsy syndrome	0.000156	0.00566	CbGeAlD
Daunorubicin—CYP1A1—head—epilepsy syndrome	0.000152	0.00552	CbGeAlD
Daunorubicin—Doxorubicin—CYP2D6—epilepsy syndrome	0.000151	0.0619	CrCbGaD
Daunorubicin—CYP1A1—nervous system—epilepsy syndrome	0.000144	0.00523	CbGeAlD
Daunorubicin—ABCG2—cerebellum—epilepsy syndrome	0.000143	0.00519	CbGeAlD
Daunorubicin—ABCC1—brain—epilepsy syndrome	0.00014	0.00509	CbGeAlD
Daunorubicin—CYP1A1—central nervous system—epilepsy syndrome	0.000139	0.00504	CbGeAlD
Daunorubicin—ABCB1—forebrain—epilepsy syndrome	0.000138	0.00501	CbGeAlD
Daunorubicin—ABCB1—telencephalon—epilepsy syndrome	0.000127	0.0046	CbGeAlD
Daunorubicin—TOP2A—Niclosamide—Clonazepam—epilepsy syndrome	0.000126	0.0703	CbGdCrCtD
Daunorubicin—ABCG2—brain—epilepsy syndrome	0.000116	0.00421	CbGeAlD
Daunorubicin—CYP1A1—brain—epilepsy syndrome	0.00011	0.004	CbGeAlD
Daunorubicin—Doxorubicin—ABCB1—epilepsy syndrome	0.000108	0.0442	CrCbGaD
Daunorubicin—TOP2A—Chlorpromazine—Clobazam—epilepsy syndrome	0.000108	0.0603	CbGdCrCtD
Daunorubicin—CYP3A4—nervous system—epilepsy syndrome	0.000106	0.00384	CbGeAlD
Daunorubicin—CYP3A4—central nervous system—epilepsy syndrome	0.000102	0.0037	CbGeAlD
Daunorubicin—ABCB1—medulla oblongata—epilepsy syndrome	9.96e-05	0.00362	CbGeAlD
Daunorubicin—ABCB1—midbrain—epilepsy syndrome	9.1e-05	0.00331	CbGeAlD
Daunorubicin—ABCB1—spinal cord—epilepsy syndrome	8.88e-05	0.00323	CbGeAlD
Daunorubicin—ABCB1—head—epilepsy syndrome	7.89e-05	0.00287	CbGeAlD
Daunorubicin—ABCB1—nervous system—epilepsy syndrome	7.48e-05	0.00272	CbGeAlD
Daunorubicin—ABCB1—central nervous system—epilepsy syndrome	7.21e-05	0.00262	CbGeAlD
Daunorubicin—ABCB1—cerebellum—epilepsy syndrome	7.04e-05	0.00256	CbGeAlD
Daunorubicin—ABCB1—brain—epilepsy syndrome	5.72e-05	0.00208	CbGeAlD
Daunorubicin—Palpitations—Pregabalin—epilepsy syndrome	4.38e-05	0.000259	CcSEcCtD
Daunorubicin—Asthenia—Phenytoin—epilepsy syndrome	4.38e-05	0.000259	CcSEcCtD
Daunorubicin—Nausea—Midazolam—epilepsy syndrome	4.37e-05	0.000259	CcSEcCtD
Daunorubicin—Hallucination—Topiramate—epilepsy syndrome	4.37e-05	0.000259	CcSEcCtD
Daunorubicin—Tachycardia—Valproic Acid—epilepsy syndrome	4.37e-05	0.000259	CcSEcCtD
Daunorubicin—Diarrhoea—Zonisamide—epilepsy syndrome	4.37e-05	0.000258	CcSEcCtD
Daunorubicin—Loss of consciousness—Pregabalin—epilepsy syndrome	4.36e-05	0.000258	CcSEcCtD
Daunorubicin—Asthenia—Oxcarbazepine—epilepsy syndrome	4.36e-05	0.000258	CcSEcCtD
Daunorubicin—Pruritus—Clonazepam—epilepsy syndrome	4.35e-05	0.000257	CcSEcCtD
Daunorubicin—Vomiting—Vigabatrin—epilepsy syndrome	4.35e-05	0.000257	CcSEcCtD
Daunorubicin—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.33e-05	0.000256	CcSEcCtD
Daunorubicin—Cough—Pregabalin—epilepsy syndrome	4.33e-05	0.000256	CcSEcCtD
Daunorubicin—Pruritus—Phenytoin—epilepsy syndrome	4.32e-05	0.000256	CcSEcCtD
Daunorubicin—Nausea—Levetiracetam—epilepsy syndrome	4.32e-05	0.000256	CcSEcCtD
Daunorubicin—Rash—Vigabatrin—epilepsy syndrome	4.31e-05	0.000255	CcSEcCtD
Daunorubicin—Dizziness—Felbamate—epilepsy syndrome	4.31e-05	0.000255	CcSEcCtD
Daunorubicin—Dermatitis—Vigabatrin—epilepsy syndrome	4.31e-05	0.000255	CcSEcCtD
Daunorubicin—Pruritus—Oxcarbazepine—epilepsy syndrome	4.3e-05	0.000254	CcSEcCtD
Daunorubicin—Convulsion—Pregabalin—epilepsy syndrome	4.3e-05	0.000254	CcSEcCtD
Daunorubicin—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.3e-05	0.000254	CcSEcCtD
Daunorubicin—Headache—Vigabatrin—epilepsy syndrome	4.29e-05	0.000254	CcSEcCtD
Daunorubicin—Hypertension—Pregabalin—epilepsy syndrome	4.28e-05	0.000253	CcSEcCtD
Daunorubicin—Vomiting—Diazepam—epilepsy syndrome	4.28e-05	0.000253	CcSEcCtD
Daunorubicin—Anorexia—Valproic Acid—epilepsy syndrome	4.27e-05	0.000253	CcSEcCtD
Daunorubicin—Tremor—Gabapentin—epilepsy syndrome	4.26e-05	0.000252	CcSEcCtD
Daunorubicin—Rash—Diazepam—epilepsy syndrome	4.25e-05	0.000251	CcSEcCtD
Daunorubicin—Dermatitis—Diazepam—epilepsy syndrome	4.24e-05	0.000251	CcSEcCtD
Daunorubicin—Visual impairment—Topiramate—epilepsy syndrome	4.24e-05	0.000251	CcSEcCtD
Daunorubicin—Arthralgia—Pregabalin—epilepsy syndrome	4.22e-05	0.00025	CcSEcCtD
Daunorubicin—Myalgia—Pregabalin—epilepsy syndrome	4.22e-05	0.00025	CcSEcCtD
Daunorubicin—Chest pain—Pregabalin—epilepsy syndrome	4.22e-05	0.00025	CcSEcCtD
Daunorubicin—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.22e-05	0.00025	CcSEcCtD
Daunorubicin—Dizziness—Zonisamide—epilepsy syndrome	4.22e-05	0.00025	CcSEcCtD
Daunorubicin—Headache—Diazepam—epilepsy syndrome	4.22e-05	0.00025	CcSEcCtD
Daunorubicin—Anxiety—Pregabalin—epilepsy syndrome	4.21e-05	0.000249	CcSEcCtD
Daunorubicin—Diarrhoea—Clonazepam—epilepsy syndrome	4.21e-05	0.000249	CcSEcCtD
Daunorubicin—Anaemia—Gabapentin—epilepsy syndrome	4.2e-05	0.000249	CcSEcCtD
Daunorubicin—Asthenia—Carbamazepine—epilepsy syndrome	4.18e-05	0.000248	CcSEcCtD
Daunorubicin—Agitation—Gabapentin—epilepsy syndrome	4.18e-05	0.000247	CcSEcCtD
Daunorubicin—Diarrhoea—Phenytoin—epilepsy syndrome	4.18e-05	0.000247	CcSEcCtD
Daunorubicin—Discomfort—Pregabalin—epilepsy syndrome	4.17e-05	0.000247	CcSEcCtD
Daunorubicin—Nausea—Fosphenytoin—epilepsy syndrome	4.17e-05	0.000247	CcSEcCtD
Daunorubicin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.16e-05	0.000246	CcSEcCtD
Daunorubicin—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.15e-05	0.000246	CcSEcCtD
Daunorubicin—Vomiting—Felbamate—epilepsy syndrome	4.14e-05	0.000245	CcSEcCtD
Daunorubicin—Dry mouth—Pregabalin—epilepsy syndrome	4.13e-05	0.000244	CcSEcCtD
Daunorubicin—Pruritus—Carbamazepine—epilepsy syndrome	4.13e-05	0.000244	CcSEcCtD
Daunorubicin—Rash—Felbamate—epilepsy syndrome	4.11e-05	0.000243	CcSEcCtD
Daunorubicin—Dermatitis—Felbamate—epilepsy syndrome	4.11e-05	0.000243	CcSEcCtD
Daunorubicin—Malaise—Gabapentin—epilepsy syndrome	4.1e-05	0.000243	CcSEcCtD
Daunorubicin—Tinnitus—Topiramate—epilepsy syndrome	4.1e-05	0.000243	CcSEcCtD
Daunorubicin—Headache—Felbamate—epilepsy syndrome	4.08e-05	0.000242	CcSEcCtD
Daunorubicin—Confusional state—Pregabalin—epilepsy syndrome	4.08e-05	0.000242	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.08e-05	0.000241	CcSEcCtD
Daunorubicin—Cardiac disorder—Topiramate—epilepsy syndrome	4.08e-05	0.000241	CcSEcCtD
Daunorubicin—Flushing—Topiramate—epilepsy syndrome	4.08e-05	0.000241	CcSEcCtD
Daunorubicin—Syncope—Gabapentin—epilepsy syndrome	4.08e-05	0.000241	CcSEcCtD
Daunorubicin—Leukopenia—Gabapentin—epilepsy syndrome	4.07e-05	0.000241	CcSEcCtD
Daunorubicin—Dizziness—Clonazepam—epilepsy syndrome	4.07e-05	0.000241	CcSEcCtD
Daunorubicin—Nausea—Vigabatrin—epilepsy syndrome	4.06e-05	0.00024	CcSEcCtD
Daunorubicin—Vomiting—Zonisamide—epilepsy syndrome	4.06e-05	0.00024	CcSEcCtD
Daunorubicin—Insomnia—Valproic Acid—epilepsy syndrome	4.05e-05	0.00024	CcSEcCtD
Daunorubicin—Anaphylactic shock—Pregabalin—epilepsy syndrome	4.05e-05	0.00024	CcSEcCtD
Daunorubicin—Oedema—Pregabalin—epilepsy syndrome	4.05e-05	0.00024	CcSEcCtD
Daunorubicin—Asthenia—Lamotrigine—epilepsy syndrome	4.04e-05	0.000239	CcSEcCtD
Daunorubicin—Dizziness—Phenytoin—epilepsy syndrome	4.04e-05	0.000239	CcSEcCtD
Daunorubicin—Rash—Zonisamide—epilepsy syndrome	4.02e-05	0.000238	CcSEcCtD
Daunorubicin—Infection—Pregabalin—epilepsy syndrome	4.02e-05	0.000238	CcSEcCtD
Daunorubicin—Palpitations—Gabapentin—epilepsy syndrome	4.02e-05	0.000238	CcSEcCtD
Daunorubicin—Dermatitis—Zonisamide—epilepsy syndrome	4.02e-05	0.000238	CcSEcCtD
Daunorubicin—Dizziness—Oxcarbazepine—epilepsy syndrome	4.02e-05	0.000238	CcSEcCtD
Daunorubicin—Nausea—Diazepam—epilepsy syndrome	4e-05	0.000237	CcSEcCtD
Daunorubicin—Loss of consciousness—Gabapentin—epilepsy syndrome	4e-05	0.000237	CcSEcCtD
Daunorubicin—Headache—Zonisamide—epilepsy syndrome	4e-05	0.000237	CcSEcCtD
Daunorubicin—Dyspnoea—Valproic Acid—epilepsy syndrome	3.99e-05	0.000236	CcSEcCtD
Daunorubicin—Diarrhoea—Carbamazepine—epilepsy syndrome	3.99e-05	0.000236	CcSEcCtD
Daunorubicin—Pruritus—Lamotrigine—epilepsy syndrome	3.99e-05	0.000236	CcSEcCtD
Daunorubicin—Shock—Pregabalin—epilepsy syndrome	3.98e-05	0.000236	CcSEcCtD
Daunorubicin—Somnolence—Valproic Acid—epilepsy syndrome	3.98e-05	0.000236	CcSEcCtD
Daunorubicin—Cough—Gabapentin—epilepsy syndrome	3.97e-05	0.000235	CcSEcCtD
Daunorubicin—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.96e-05	0.000235	CcSEcCtD
Daunorubicin—Tachycardia—Pregabalin—epilepsy syndrome	3.95e-05	0.000234	CcSEcCtD
Daunorubicin—Chills—Topiramate—epilepsy syndrome	3.94e-05	0.000233	CcSEcCtD
Daunorubicin—Convulsion—Gabapentin—epilepsy syndrome	3.94e-05	0.000233	CcSEcCtD
Daunorubicin—Hypertension—Gabapentin—epilepsy syndrome	3.93e-05	0.000232	CcSEcCtD
Daunorubicin—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.91e-05	0.000232	CcSEcCtD
Daunorubicin—Vomiting—Clonazepam—epilepsy syndrome	3.91e-05	0.000231	CcSEcCtD
Daunorubicin—Decreased appetite—Valproic Acid—epilepsy syndrome	3.89e-05	0.00023	CcSEcCtD
Daunorubicin—Alopecia—Topiramate—epilepsy syndrome	3.88e-05	0.00023	CcSEcCtD
Daunorubicin—Vomiting—Phenytoin—epilepsy syndrome	3.88e-05	0.00023	CcSEcCtD
Daunorubicin—Rash—Clonazepam—epilepsy syndrome	3.88e-05	0.000229	CcSEcCtD
Daunorubicin—Dermatitis—Clonazepam—epilepsy syndrome	3.87e-05	0.000229	CcSEcCtD
Daunorubicin—Arthralgia—Gabapentin—epilepsy syndrome	3.87e-05	0.000229	CcSEcCtD
Daunorubicin—Chest pain—Gabapentin—epilepsy syndrome	3.87e-05	0.000229	CcSEcCtD
Daunorubicin—Myalgia—Gabapentin—epilepsy syndrome	3.87e-05	0.000229	CcSEcCtD
Daunorubicin—Nausea—Felbamate—epilepsy syndrome	3.87e-05	0.000229	CcSEcCtD
Daunorubicin—Vomiting—Oxcarbazepine—epilepsy syndrome	3.86e-05	0.000229	CcSEcCtD
Daunorubicin—Fatigue—Valproic Acid—epilepsy syndrome	3.86e-05	0.000228	CcSEcCtD
Daunorubicin—Anxiety—Gabapentin—epilepsy syndrome	3.86e-05	0.000228	CcSEcCtD
Daunorubicin—Anorexia—Pregabalin—epilepsy syndrome	3.86e-05	0.000228	CcSEcCtD
Daunorubicin—Dizziness—Carbamazepine—epilepsy syndrome	3.86e-05	0.000228	CcSEcCtD
Daunorubicin—Diarrhoea—Lamotrigine—epilepsy syndrome	3.86e-05	0.000228	CcSEcCtD
Daunorubicin—Headache—Clonazepam—epilepsy syndrome	3.85e-05	0.000228	CcSEcCtD
Daunorubicin—Rash—Phenytoin—epilepsy syndrome	3.85e-05	0.000228	CcSEcCtD
Daunorubicin—Dermatitis—Phenytoin—epilepsy syndrome	3.85e-05	0.000228	CcSEcCtD
Daunorubicin—Rash—Oxcarbazepine—epilepsy syndrome	3.83e-05	0.000227	CcSEcCtD
Daunorubicin—Constipation—Valproic Acid—epilepsy syndrome	3.83e-05	0.000227	CcSEcCtD
Daunorubicin—Pain—Valproic Acid—epilepsy syndrome	3.83e-05	0.000227	CcSEcCtD
Daunorubicin—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.83e-05	0.000227	CcSEcCtD
Daunorubicin—Headache—Phenytoin—epilepsy syndrome	3.83e-05	0.000226	CcSEcCtD
Daunorubicin—Erythema—Topiramate—epilepsy syndrome	3.83e-05	0.000226	CcSEcCtD
Daunorubicin—Discomfort—Gabapentin—epilepsy syndrome	3.83e-05	0.000226	CcSEcCtD
Daunorubicin—Headache—Oxcarbazepine—epilepsy syndrome	3.81e-05	0.000225	CcSEcCtD
Daunorubicin—Nausea—Zonisamide—epilepsy syndrome	3.79e-05	0.000224	CcSEcCtD
Daunorubicin—Dry mouth—Gabapentin—epilepsy syndrome	3.79e-05	0.000224	CcSEcCtD
Daunorubicin—Dysgeusia—Topiramate—epilepsy syndrome	3.75e-05	0.000222	CcSEcCtD
Daunorubicin—Confusional state—Gabapentin—epilepsy syndrome	3.74e-05	0.000222	CcSEcCtD
Daunorubicin—Dizziness—Lamotrigine—epilepsy syndrome	3.73e-05	0.000221	CcSEcCtD
Daunorubicin—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.71e-05	0.00022	CcSEcCtD
Daunorubicin—Oedema—Gabapentin—epilepsy syndrome	3.71e-05	0.00022	CcSEcCtD
Daunorubicin—Vomiting—Carbamazepine—epilepsy syndrome	3.71e-05	0.000219	CcSEcCtD
Daunorubicin—Back pain—Topiramate—epilepsy syndrome	3.7e-05	0.000219	CcSEcCtD
Daunorubicin—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.69e-05	0.000218	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.69e-05	0.000218	CcSEcCtD
Daunorubicin—Infection—Gabapentin—epilepsy syndrome	3.69e-05	0.000218	CcSEcCtD
Daunorubicin—Rash—Carbamazepine—epilepsy syndrome	3.68e-05	0.000218	CcSEcCtD
Daunorubicin—Dermatitis—Carbamazepine—epilepsy syndrome	3.67e-05	0.000217	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.66e-05	0.000217	CcSEcCtD
Daunorubicin—Insomnia—Pregabalin—epilepsy syndrome	3.66e-05	0.000217	CcSEcCtD
Daunorubicin—Nausea—Clonazepam—epilepsy syndrome	3.65e-05	0.000216	CcSEcCtD
Daunorubicin—Headache—Carbamazepine—epilepsy syndrome	3.65e-05	0.000216	CcSEcCtD
Daunorubicin—Shock—Gabapentin—epilepsy syndrome	3.65e-05	0.000216	CcSEcCtD
Daunorubicin—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.63e-05	0.000215	CcSEcCtD
Daunorubicin—Nausea—Phenytoin—epilepsy syndrome	3.63e-05	0.000215	CcSEcCtD
Daunorubicin—Tachycardia—Gabapentin—epilepsy syndrome	3.62e-05	0.000214	CcSEcCtD
Daunorubicin—Dyspnoea—Pregabalin—epilepsy syndrome	3.61e-05	0.000214	CcSEcCtD
Daunorubicin—Nausea—Oxcarbazepine—epilepsy syndrome	3.61e-05	0.000214	CcSEcCtD
Daunorubicin—Somnolence—Pregabalin—epilepsy syndrome	3.6e-05	0.000213	CcSEcCtD
Daunorubicin—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.59e-05	0.000212	CcSEcCtD
Daunorubicin—Tremor—Topiramate—epilepsy syndrome	3.59e-05	0.000212	CcSEcCtD
Daunorubicin—Vomiting—Lamotrigine—epilepsy syndrome	3.58e-05	0.000212	CcSEcCtD
Daunorubicin—Urticaria—Valproic Acid—epilepsy syndrome	3.56e-05	0.000211	CcSEcCtD
Daunorubicin—Rash—Lamotrigine—epilepsy syndrome	3.55e-05	0.00021	CcSEcCtD
Daunorubicin—Ill-defined disorder—Topiramate—epilepsy syndrome	3.55e-05	0.00021	CcSEcCtD
Daunorubicin—Dermatitis—Lamotrigine—epilepsy syndrome	3.55e-05	0.00021	CcSEcCtD
Daunorubicin—Abdominal pain—Valproic Acid—epilepsy syndrome	3.54e-05	0.000209	CcSEcCtD
Daunorubicin—Body temperature increased—Valproic Acid—epilepsy syndrome	3.54e-05	0.000209	CcSEcCtD
Daunorubicin—Anorexia—Gabapentin—epilepsy syndrome	3.54e-05	0.000209	CcSEcCtD
Daunorubicin—Anaemia—Topiramate—epilepsy syndrome	3.54e-05	0.000209	CcSEcCtD
Daunorubicin—Headache—Lamotrigine—epilepsy syndrome	3.53e-05	0.000209	CcSEcCtD
Daunorubicin—Decreased appetite—Pregabalin—epilepsy syndrome	3.52e-05	0.000208	CcSEcCtD
Daunorubicin—Agitation—Topiramate—epilepsy syndrome	3.52e-05	0.000208	CcSEcCtD
Daunorubicin—Fatigue—Pregabalin—epilepsy syndrome	3.49e-05	0.000207	CcSEcCtD
Daunorubicin—Nausea—Carbamazepine—epilepsy syndrome	3.46e-05	0.000205	CcSEcCtD
Daunorubicin—Pain—Pregabalin—epilepsy syndrome	3.46e-05	0.000205	CcSEcCtD
Daunorubicin—Constipation—Pregabalin—epilepsy syndrome	3.46e-05	0.000205	CcSEcCtD
Daunorubicin—Malaise—Topiramate—epilepsy syndrome	3.45e-05	0.000204	CcSEcCtD
Daunorubicin—Syncope—Topiramate—epilepsy syndrome	3.43e-05	0.000203	CcSEcCtD
Daunorubicin—Leukopenia—Topiramate—epilepsy syndrome	3.43e-05	0.000203	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.38e-05	0.0002	CcSEcCtD
Daunorubicin—Palpitations—Topiramate—epilepsy syndrome	3.38e-05	0.0002	CcSEcCtD
Daunorubicin—Loss of consciousness—Topiramate—epilepsy syndrome	3.36e-05	0.000199	CcSEcCtD
Daunorubicin—Insomnia—Gabapentin—epilepsy syndrome	3.36e-05	0.000199	CcSEcCtD
Daunorubicin—Nausea—Lamotrigine—epilepsy syndrome	3.35e-05	0.000198	CcSEcCtD
Daunorubicin—Cough—Topiramate—epilepsy syndrome	3.34e-05	0.000198	CcSEcCtD
Daunorubicin—Feeling abnormal—Pregabalin—epilepsy syndrome	3.34e-05	0.000197	CcSEcCtD
Daunorubicin—Convulsion—Topiramate—epilepsy syndrome	3.32e-05	0.000196	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.31e-05	0.000196	CcSEcCtD
Daunorubicin—Dyspnoea—Gabapentin—epilepsy syndrome	3.31e-05	0.000196	CcSEcCtD
Daunorubicin—Hypertension—Topiramate—epilepsy syndrome	3.3e-05	0.000196	CcSEcCtD
Daunorubicin—Somnolence—Gabapentin—epilepsy syndrome	3.3e-05	0.000195	CcSEcCtD
Daunorubicin—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.3e-05	0.000195	CcSEcCtD
Daunorubicin—Arthralgia—Topiramate—epilepsy syndrome	3.26e-05	0.000193	CcSEcCtD
Daunorubicin—Myalgia—Topiramate—epilepsy syndrome	3.26e-05	0.000193	CcSEcCtD
Daunorubicin—Chest pain—Topiramate—epilepsy syndrome	3.26e-05	0.000193	CcSEcCtD
Daunorubicin—Anxiety—Topiramate—epilepsy syndrome	3.25e-05	0.000192	CcSEcCtD
Daunorubicin—Decreased appetite—Gabapentin—epilepsy syndrome	3.23e-05	0.000191	CcSEcCtD
Daunorubicin—Discomfort—Topiramate—epilepsy syndrome	3.22e-05	0.00019	CcSEcCtD
Daunorubicin—Urticaria—Pregabalin—epilepsy syndrome	3.22e-05	0.00019	CcSEcCtD
Daunorubicin—Asthenia—Valproic Acid—epilepsy syndrome	3.21e-05	0.00019	CcSEcCtD
Daunorubicin—Fatigue—Gabapentin—epilepsy syndrome	3.2e-05	0.000189	CcSEcCtD
Daunorubicin—Body temperature increased—Pregabalin—epilepsy syndrome	3.2e-05	0.000189	CcSEcCtD
Daunorubicin—Abdominal pain—Pregabalin—epilepsy syndrome	3.2e-05	0.000189	CcSEcCtD
Daunorubicin—Dry mouth—Topiramate—epilepsy syndrome	3.19e-05	0.000189	CcSEcCtD
Daunorubicin—Pain—Gabapentin—epilepsy syndrome	3.17e-05	0.000188	CcSEcCtD
Daunorubicin—Constipation—Gabapentin—epilepsy syndrome	3.17e-05	0.000188	CcSEcCtD
Daunorubicin—Pruritus—Valproic Acid—epilepsy syndrome	3.17e-05	0.000187	CcSEcCtD
Daunorubicin—Confusional state—Topiramate—epilepsy syndrome	3.15e-05	0.000186	CcSEcCtD
Daunorubicin—Oedema—Topiramate—epilepsy syndrome	3.12e-05	0.000185	CcSEcCtD
Daunorubicin—Infection—Topiramate—epilepsy syndrome	3.1e-05	0.000184	CcSEcCtD
Daunorubicin—Shock—Topiramate—epilepsy syndrome	3.07e-05	0.000182	CcSEcCtD
Daunorubicin—Diarrhoea—Valproic Acid—epilepsy syndrome	3.06e-05	0.000181	CcSEcCtD
Daunorubicin—Feeling abnormal—Gabapentin—epilepsy syndrome	3.06e-05	0.000181	CcSEcCtD
Daunorubicin—Thrombocytopenia—Topiramate—epilepsy syndrome	3.06e-05	0.000181	CcSEcCtD
Daunorubicin—Tachycardia—Topiramate—epilepsy syndrome	3.05e-05	0.00018	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.04e-05	0.00018	CcSEcCtD
Daunorubicin—Hyperhidrosis—Topiramate—epilepsy syndrome	3.02e-05	0.000179	CcSEcCtD
Daunorubicin—Hypersensitivity—Pregabalin—epilepsy syndrome	2.98e-05	0.000177	CcSEcCtD
Daunorubicin—Anorexia—Topiramate—epilepsy syndrome	2.98e-05	0.000176	CcSEcCtD
Daunorubicin—Dizziness—Valproic Acid—epilepsy syndrome	2.96e-05	0.000175	CcSEcCtD
Daunorubicin—Urticaria—Gabapentin—epilepsy syndrome	2.95e-05	0.000175	CcSEcCtD
Daunorubicin—Abdominal pain—Gabapentin—epilepsy syndrome	2.93e-05	0.000174	CcSEcCtD
Daunorubicin—Body temperature increased—Gabapentin—epilepsy syndrome	2.93e-05	0.000174	CcSEcCtD
Daunorubicin—Asthenia—Pregabalin—epilepsy syndrome	2.9e-05	0.000172	CcSEcCtD
Daunorubicin—Pruritus—Pregabalin—epilepsy syndrome	2.86e-05	0.00017	CcSEcCtD
Daunorubicin—Vomiting—Valproic Acid—epilepsy syndrome	2.85e-05	0.000168	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.85e-05	0.000168	CcSEcCtD
Daunorubicin—Insomnia—Topiramate—epilepsy syndrome	2.82e-05	0.000167	CcSEcCtD
Daunorubicin—Rash—Valproic Acid—epilepsy syndrome	2.82e-05	0.000167	CcSEcCtD
Daunorubicin—Dermatitis—Valproic Acid—epilepsy syndrome	2.82e-05	0.000167	CcSEcCtD
Daunorubicin—Headache—Valproic Acid—epilepsy syndrome	2.81e-05	0.000166	CcSEcCtD
Daunorubicin—Dyspnoea—Topiramate—epilepsy syndrome	2.78e-05	0.000165	CcSEcCtD
Daunorubicin—Somnolence—Topiramate—epilepsy syndrome	2.78e-05	0.000164	CcSEcCtD
Daunorubicin—Diarrhoea—Pregabalin—epilepsy syndrome	2.77e-05	0.000164	CcSEcCtD
Daunorubicin—Hypersensitivity—Gabapentin—epilepsy syndrome	2.73e-05	0.000162	CcSEcCtD
Daunorubicin—Decreased appetite—Topiramate—epilepsy syndrome	2.71e-05	0.000161	CcSEcCtD
Daunorubicin—Fatigue—Topiramate—epilepsy syndrome	2.69e-05	0.000159	CcSEcCtD
Daunorubicin—Dizziness—Pregabalin—epilepsy syndrome	2.68e-05	0.000158	CcSEcCtD
Daunorubicin—Pain—Topiramate—epilepsy syndrome	2.67e-05	0.000158	CcSEcCtD
Daunorubicin—Constipation—Topiramate—epilepsy syndrome	2.67e-05	0.000158	CcSEcCtD
Daunorubicin—Asthenia—Gabapentin—epilepsy syndrome	2.66e-05	0.000158	CcSEcCtD
Daunorubicin—Nausea—Valproic Acid—epilepsy syndrome	2.66e-05	0.000157	CcSEcCtD
Daunorubicin—Pruritus—Gabapentin—epilepsy syndrome	2.63e-05	0.000155	CcSEcCtD
Daunorubicin—Vomiting—Pregabalin—epilepsy syndrome	2.57e-05	0.000152	CcSEcCtD
Daunorubicin—Feeling abnormal—Topiramate—epilepsy syndrome	2.57e-05	0.000152	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.55e-05	0.000151	CcSEcCtD
Daunorubicin—Rash—Pregabalin—epilepsy syndrome	2.55e-05	0.000151	CcSEcCtD
Daunorubicin—Dermatitis—Pregabalin—epilepsy syndrome	2.55e-05	0.000151	CcSEcCtD
Daunorubicin—Diarrhoea—Gabapentin—epilepsy syndrome	2.54e-05	0.00015	CcSEcCtD
Daunorubicin—Headache—Pregabalin—epilepsy syndrome	2.54e-05	0.00015	CcSEcCtD
Daunorubicin—Urticaria—Topiramate—epilepsy syndrome	2.48e-05	0.000147	CcSEcCtD
Daunorubicin—Body temperature increased—Topiramate—epilepsy syndrome	2.47e-05	0.000146	CcSEcCtD
Daunorubicin—Abdominal pain—Topiramate—epilepsy syndrome	2.47e-05	0.000146	CcSEcCtD
Daunorubicin—Dizziness—Gabapentin—epilepsy syndrome	2.45e-05	0.000145	CcSEcCtD
Daunorubicin—Nausea—Pregabalin—epilepsy syndrome	2.4e-05	0.000142	CcSEcCtD
Daunorubicin—Vomiting—Gabapentin—epilepsy syndrome	2.36e-05	0.00014	CcSEcCtD
Daunorubicin—Rash—Gabapentin—epilepsy syndrome	2.34e-05	0.000139	CcSEcCtD
Daunorubicin—Dermatitis—Gabapentin—epilepsy syndrome	2.34e-05	0.000138	CcSEcCtD
Daunorubicin—Headache—Gabapentin—epilepsy syndrome	2.33e-05	0.000138	CcSEcCtD
Daunorubicin—Hypersensitivity—Topiramate—epilepsy syndrome	2.3e-05	0.000136	CcSEcCtD
Daunorubicin—Asthenia—Topiramate—epilepsy syndrome	2.24e-05	0.000133	CcSEcCtD
Daunorubicin—Pruritus—Topiramate—epilepsy syndrome	2.21e-05	0.000131	CcSEcCtD
Daunorubicin—Nausea—Gabapentin—epilepsy syndrome	2.2e-05	0.00013	CcSEcCtD
Daunorubicin—Diarrhoea—Topiramate—epilepsy syndrome	2.14e-05	0.000126	CcSEcCtD
Daunorubicin—Dizziness—Topiramate—epilepsy syndrome	2.07e-05	0.000122	CcSEcCtD
Daunorubicin—Vomiting—Topiramate—epilepsy syndrome	1.99e-05	0.000118	CcSEcCtD
Daunorubicin—Rash—Topiramate—epilepsy syndrome	1.97e-05	0.000117	CcSEcCtD
Daunorubicin—Dermatitis—Topiramate—epilepsy syndrome	1.97e-05	0.000116	CcSEcCtD
Daunorubicin—Headache—Topiramate—epilepsy syndrome	1.96e-05	0.000116	CcSEcCtD
Daunorubicin—Nausea—Topiramate—epilepsy syndrome	1.86e-05	0.00011	CcSEcCtD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.53e-06	5.29e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—SLC2A1—epilepsy syndrome	4.51e-06	5.27e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP2D6—epilepsy syndrome	4.49e-06	5.25e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PLCB1—epilepsy syndrome	4.46e-06	5.22e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	4.45e-06	5.2e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—TH—epilepsy syndrome	4.45e-06	5.2e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	4.42e-06	5.16e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.38e-06	5.12e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ADSL—epilepsy syndrome	4.36e-06	5.09e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—QDPR—epilepsy syndrome	4.35e-06	5.08e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CA4—epilepsy syndrome	4.35e-06	5.08e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	4.33e-06	5.06e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.33e-06	5.06e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	4.32e-06	5.05e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—KCNJ11—epilepsy syndrome	4.31e-06	5.04e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CHRM3—epilepsy syndrome	4.31e-06	5.04e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—BCHE—epilepsy syndrome	4.3e-06	5.03e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HES1—epilepsy syndrome	4.3e-06	5.02e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.28e-06	5.01e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ADRA2A—epilepsy syndrome	4.28e-06	5e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GLUL—epilepsy syndrome	4.27e-06	4.99e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GBE1—epilepsy syndrome	4.27e-06	4.99e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	4.27e-06	4.99e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—BCHE—epilepsy syndrome	4.26e-06	4.98e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	4.2e-06	4.9e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—FYN—epilepsy syndrome	4.18e-06	4.88e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	4.17e-06	4.87e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	4.17e-06	4.87e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—H2AFX—epilepsy syndrome	4.16e-06	4.86e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—ALB—epilepsy syndrome	4.16e-06	4.86e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	4.11e-06	4.8e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—COX3—epilepsy syndrome	4.09e-06	4.77e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SLC2A1—epilepsy syndrome	4.06e-06	4.75e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	4.06e-06	4.75e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PLCB1—epilepsy syndrome	4.06e-06	4.75e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—TH—epilepsy syndrome	4.05e-06	4.73e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PLCB1—epilepsy syndrome	4.02e-06	4.7e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.02e-06	4.69e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—YWHAZ—epilepsy syndrome	4.02e-06	4.69e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	4.01e-06	4.69e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—TH—epilepsy syndrome	4e-06	4.68e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AGT—epilepsy syndrome	4e-06	4.67e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.94e-06	4.6e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	3.92e-06	4.58e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—APOE—epilepsy syndrome	3.92e-06	4.58e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	3.9e-06	4.56e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.9e-06	4.56e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	3.87e-06	4.53e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	3.87e-06	4.53e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PFKL—epilepsy syndrome	3.87e-06	4.53e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	3.87e-06	4.53e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	3.87e-06	4.53e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.86e-06	4.51e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CCR5—epilepsy syndrome	3.86e-06	4.51e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—HMOX1—epilepsy syndrome	3.84e-06	4.48e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AQP1—epilepsy syndrome	3.81e-06	4.45e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NT5E—epilepsy syndrome	3.8e-06	4.44e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALAD—epilepsy syndrome	3.8e-06	4.44e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CAT—epilepsy syndrome	3.79e-06	4.42e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	3.72e-06	4.35e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—HMOX1—epilepsy syndrome	3.71e-06	4.34e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ABCB1—epilepsy syndrome	3.68e-06	4.3e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CAT—epilepsy syndrome	3.66e-06	4.28e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTGS2—epilepsy syndrome	3.64e-06	4.25e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	3.63e-06	4.24e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	3.63e-06	4.24e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	3.63e-06	4.24e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	3.6e-06	4.21e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TSC2—epilepsy syndrome	3.59e-06	4.2e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ABCB1—epilepsy syndrome	3.56e-06	4.16e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	3.55e-06	4.15e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.54e-06	4.14e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.54e-06	4.14e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.54e-06	4.14e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ABCG2—epilepsy syndrome	3.52e-06	4.11e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—APOE—epilepsy syndrome	3.51e-06	4.11e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	3.48e-06	4.07e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ADSL—epilepsy syndrome	3.48e-06	4.07e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CHRM3—epilepsy syndrome	3.44e-06	4.03e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	3.44e-06	4.03e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	3.43e-06	4e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GPX1—epilepsy syndrome	3.42e-06	4e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GLUL—epilepsy syndrome	3.41e-06	3.99e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.41e-06	3.98e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	3.41e-06	3.98e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.38e-06	3.95e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—HMOX1—epilepsy syndrome	3.38e-06	3.95e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—POMC—epilepsy syndrome	3.36e-06	3.93e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	3.35e-06	3.91e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—HMOX1—epilepsy syndrome	3.34e-06	3.91e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CAT—epilepsy syndrome	3.33e-06	3.89e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GPX1—epilepsy syndrome	3.31e-06	3.87e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—IL6ST—epilepsy syndrome	3.3e-06	3.86e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CAT—epilepsy syndrome	3.3e-06	3.85e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.29e-06	3.85e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.29e-06	3.85e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NOS2—epilepsy syndrome	3.27e-06	3.83e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	3.25e-06	3.8e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ABCB1—epilepsy syndrome	3.24e-06	3.79e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ABCB1—epilepsy syndrome	3.21e-06	3.75e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	3.13e-06	3.66e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.1e-06	3.62e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	3.1e-06	3.62e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—BCHE—epilepsy syndrome	3.08e-06	3.6e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.08e-06	3.6e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	3.07e-06	3.59e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ALB—epilepsy syndrome	3.07e-06	3.58e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AQP1—epilepsy syndrome	3.04e-06	3.55e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GPX1—epilepsy syndrome	3.01e-06	3.52e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	3.01e-06	3.52e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AGT—epilepsy syndrome	3e-06	3.51e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GPX1—epilepsy syndrome	2.98e-06	3.48e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—APOE—epilepsy syndrome	2.94e-06	3.44e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	2.94e-06	3.44e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.94e-06	3.43e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.94e-06	3.43e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	2.93e-06	3.42e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.92e-06	3.41e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—BCHE—epilepsy syndrome	2.91e-06	3.4e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	2.91e-06	3.4e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AGT—epilepsy syndrome	2.9e-06	3.39e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—TH—epilepsy syndrome	2.9e-06	3.39e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—APOE—epilepsy syndrome	2.85e-06	3.33e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ABCG2—epilepsy syndrome	2.81e-06	3.28e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.8e-06	3.27e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.8e-06	3.27e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	2.78e-06	3.25e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	2.75e-06	3.21e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	2.75e-06	3.21e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	2.75e-06	3.21e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.74e-06	3.2e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—TH—epilepsy syndrome	2.74e-06	3.2e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	2.74e-06	3.2e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	2.72e-06	3.18e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.7e-06	3.15e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.69e-06	3.14e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTGS2—epilepsy syndrome	2.68e-06	3.14e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—FGF2—epilepsy syndrome	2.67e-06	3.12e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AGT—epilepsy syndrome	2.64e-06	3.09e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.63e-06	3.08e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AGT—epilepsy syndrome	2.62e-06	3.06e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.59e-06	3.03e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—APOE—epilepsy syndrome	2.59e-06	3.03e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.58e-06	3.02e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—APOE—epilepsy syndrome	2.56e-06	2.99e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.56e-06	2.99e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—POMC—epilepsy syndrome	2.53e-06	2.95e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.51e-06	2.93e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.45e-06	2.87e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—POMC—epilepsy syndrome	2.44e-06	2.86e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MTOR—epilepsy syndrome	2.43e-06	2.84e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	2.42e-06	2.83e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.42e-06	2.82e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTGS2—epilepsy syndrome	2.41e-06	2.81e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CAT—epilepsy syndrome	2.39e-06	2.79e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.35e-06	2.74e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.34e-06	2.74e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.34e-06	2.73e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.33e-06	2.72e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	2.32e-06	2.71e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ALB—epilepsy syndrome	2.3e-06	2.69e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	2.29e-06	2.67e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CAT—epilepsy syndrome	2.26e-06	2.64e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	2.24e-06	2.62e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ALB—epilepsy syndrome	2.23e-06	2.6e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—POMC—epilepsy syndrome	2.22e-06	2.6e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.22e-06	2.59e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—POMC—epilepsy syndrome	2.2e-06	2.57e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.2e-06	2.57e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	2.19e-06	2.56e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TH—epilepsy syndrome	2.19e-06	2.56e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	2.18e-06	2.55e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	2.17e-06	2.54e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GPX1—epilepsy syndrome	2.16e-06	2.52e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.16e-06	2.52e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.12e-06	2.48e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.12e-06	2.48e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GPX1—epilepsy syndrome	2.04e-06	2.38e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ALB—epilepsy syndrome	2.03e-06	2.37e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTGS2—epilepsy syndrome	2.02e-06	2.36e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ALB—epilepsy syndrome	2.01e-06	2.34e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.97e-06	2.3e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.96e-06	2.29e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTGS2—epilepsy syndrome	1.95e-06	2.28e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SRC—epilepsy syndrome	1.95e-06	2.28e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.89e-06	2.21e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.87e-06	2.18e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.86e-06	2.17e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.86e-06	2.17e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—AKT1—epilepsy syndrome	1.83e-06	2.14e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.83e-06	2.13e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CAT—epilepsy syndrome	1.8e-06	2.11e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AGT—epilepsy syndrome	1.79e-06	2.09e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTGS2—epilepsy syndrome	1.77e-06	2.07e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.77e-06	2.07e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	1.76e-06	2.05e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.75e-06	2.05e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—APOE—epilepsy syndrome	1.75e-06	2.05e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TH—epilepsy syndrome	1.75e-06	2.04e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.73e-06	2.02e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.72e-06	2.01e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.69e-06	1.97e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.68e-06	1.96e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.63e-06	1.9e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.59e-06	1.86e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.51e-06	1.77e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—POMC—epilepsy syndrome	1.51e-06	1.76e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.46e-06	1.7e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.45e-06	1.7e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.44e-06	1.68e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.44e-06	1.68e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.43e-06	1.68e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AGT—epilepsy syndrome	1.43e-06	1.67e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—APOE—epilepsy syndrome	1.4e-06	1.64e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.4e-06	1.63e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ALB—epilepsy syndrome	1.37e-06	1.6e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.37e-06	1.6e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.35e-06	1.58e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AKT1—epilepsy syndrome	1.35e-06	1.58e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TH—epilepsy syndrome	1.35e-06	1.57e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.3e-06	1.52e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.27e-06	1.49e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKT1—epilepsy syndrome	1.21e-06	1.41e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—POMC—epilepsy syndrome	1.2e-06	1.41e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	1.2e-06	1.4e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.14e-06	1.33e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.13e-06	1.31e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.12e-06	1.31e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.11e-06	1.3e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ALB—epilepsy syndrome	1.1e-06	1.28e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.08e-06	1.26e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKT1—epilepsy syndrome	1.01e-06	1.18e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1e-06	1.17e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKT1—epilepsy syndrome	9.8e-07	1.15e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—POMC—epilepsy syndrome	9.6e-07	1.12e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS2—epilepsy syndrome	9.59e-07	1.12e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKT1—epilepsy syndrome	8.92e-07	1.04e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKT1—epilepsy syndrome	8.82e-07	1.03e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AGT—epilepsy syndrome	8.8e-07	1.03e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALB—epilepsy syndrome	8.75e-07	1.02e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—APOE—epilepsy syndrome	8.62e-07	1.01e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	7.66e-07	8.95e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—POMC—epilepsy syndrome	7.41e-07	8.66e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALB—epilepsy syndrome	6.75e-07	7.89e-06	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKT1—epilepsy syndrome	6.39e-07	7.46e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKT1—epilepsy syndrome	6.04e-07	7.05e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.91e-07	6.91e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKT1—epilepsy syndrome	4.82e-07	5.63e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKT1—epilepsy syndrome	3.85e-07	4.5e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.97e-07	3.47e-06	CbGpPWpGaD
